Developers, not doctors, should be held accountable for generative AI medical devices, providers say

Provider groups are lobbying the FDA to make technology companies responsible for the safety and performance of generative AI-backed medical devices, arguing that tool makers are best equipped to evaluate them. This addresses regulatory accountability in the emerging AI medical device market.